Sector
HealthcareOpen
₹32.6Prev. Close
₹32.85Turnover(Lac.)
₹2.97Day's High
₹33.6Day's Low
₹32.5552 Week's High
₹52.452 Week's Low
₹27Book Value
₹47.63Face Value
₹10Mkt Cap (₹ Cr.)
45.87P/E
21.9EPS
1.5Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 13.9 | 13.9 | 9.9 | 9.9 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 55.54 | 52 | 3.43 | 1.13 |
Net Worth | 69.44 | 65.9 | 13.33 | 11.03 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Revenue | 20.79 | 22.18 | 20.6 |
yoy growth (%) | -6.26 | 7.64 | |
Raw materials | -2.2 | -2.54 | -1.72 |
As % of sales | 10.62 | 11.47 | 8.34 |
Employee costs | -2.68 | -2.85 | -2.43 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Profit before tax | 3.3 | 0.71 | 0.22 |
Depreciation | -3.18 | -3.18 | -3.23 |
Tax paid | -0.99 | 0 | 0 |
Working capital | -3.88 | 6.08 | |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -6.26 | 7.64 | |
Op profit growth | 16.37 | -2.65 | |
EBIT growth | 51.76 | -10.41 | |
Net profit growth | 222.19 | 219.73 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,402.15 | 91.17 | 92,133.61 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 930.3 | 131.53 | 90,378.13 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 493.25 | 300.21 | 37,170.36 | 68.33 | 0.2 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,195.7 | 88.77 | 31,985.94 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,254.1 | 60.4 | 25,637.06 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Edwin Francis Dabre
Executive Director & CFO
Tejal Anil Jayakar
Non Executive Director
Krupesh Deepak Thakur
Independent Director
Nilesh Ghanshyam Bide
Independent Director
Abhinay Shashikant Nerurkar
Independent Director
Karim Hakam Khimani
Company Secretary
Akshay Joshi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Nidan Laboratories & Healthcare Ltd
Summary
The Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, name of the Company changed from Abhi Diagnostic Imagings Private Limited to Nidan Laboratories And Healthcare Private Limited under the Companies Act, 2013 pursuant to a Special Resolution passed by Shareholders at the EGM held on February 26, 2021 and had obtained fresh Certificate of Incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, Company got converted into a Public Limited Company and name of the Company was changed to Nidan Laboratories And Healthcare Limited and a fresh Certificate of Incorporation consequent upon conversion to Public Limited Company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The Company carry on the business of Diagnostic Centre, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI etc., Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.Nidan was established as a Proprietary Firm in 1994 by Promoter, Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The Company came into existence in the year 2000. The business was carried out under the sole proprietorship, which was
Read More
The Nidan Laboratories & Healthcare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹33 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nidan Laboratories & Healthcare Ltd is ₹45.87 Cr. as of 23 Jul ‘24
The PE and PB ratios of Nidan Laboratories & Healthcare Ltd is 21.9 and 0.69 as of 23 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Nidan Laboratories & Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Nidan Laboratories & Healthcare Ltd is ₹27 and ₹52.4 as of 23 Jul ‘24
Nidan Laboratories & Healthcare Ltd's CAGR for 5 Years at N/I%, 3 Years at -34.66%, 1 Year at -24.05%, 6 Month at -8.37%, 3 Month at 10.79% and 1 Month at -3.95%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.